Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations

  • Rai, Vandana (Department of Biotechnology, Faculty of Sciences, VBS Purvanchal University)
  • Published : 2016.01.11


Background: Genetic and environmental factors play important roles in pathogenesis of digestive tract cancers like those in the esophagus, stomach and colorectum. Folate deficiency and methylenetetrahydrofolate reductase (MTHFR) as an important enzyme of folate and methionine metabolism are considered crucial for DNA synthesis and methylation. MTHFR variants may cause genomic hypomethylation, which may lead to the development of cancer, and MTHFR gene polymorphisms (especially C677T and A1298C) are known to influence predispositions for cancer development. Several case control association studies of MTHFR C677T polymorphisms and colorectal cancer (CRC) have been reported in different populations with contrasting results, possibly reflecting inadequate statistical power. Aim: The present meta-analysis was conducted to investigate the association between the C677T polymorphism and the risk of colorectal cancer. Materials and Methods: A literature search of the PubMed, Google Scholar, Springer link and Elsevier databases was carried out for potential relevant articles. Pooled odds ratio (OR) with corresponding 95 % confidence interval (95 % CI) was calculated to assess the association of MTHFR C677T with the susceptibility to CRC. Cochran's Q statistic and the inconsistency index (I2) were used to check study heterogeneity. Egger's test and funnel plots were applied to assess publication bias. All statistical analyses were conducted by with MetaAnalyst and MIX version 1.7. Results: Thirty four case-control studies involving a total of 9,143 cases and 11,357 controls were retrieved according to the inclusion criteria. Overall, no significant association was found between the MTHFR C677T polymorphism and colorectal cancer in Asian populations (for T vs. C: OR=1.03; 95% CI= 0.92-1.5; p= 0.64; for TT vs CC: OR=0.88; 95%CI= 0.74-1.04; p= 0.04; for CT vs. CC: OR = 1.02; 95%CI= 0.93-1.12; p=0.59; for TT+ CT vs. CC: OR=1.07; 95%CI= 0.94-1.22; p=0.87). Conclusions: Evidence from the current meta-analysis indicated that the C677T polymorphism is not associated with CRC risk in Asian populations. Further investigations are needed to offer better insight into any role of this polymorphism in colorectal carcinogenesis.


Colorectal cancer;MTHFR;C677T;meta-analysis;homocysteine;folate


  1. Ames BN (2001). DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res, 475, 7-20.
  2. Bax L, Yu LM, Ikeda N, Tsuruta H. Moons KG (2006). Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol, 6, 50.
  3. Bedine MS (1999). Colorectal carcinoma: etiology, diagnosis, and screening. Compr Ther, 25, 163-8.
  4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
  5. Bai JL, Zheng MH, Xia X, et al (2009). MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls. Eur J Cancer, 45, 1443-9.
  6. Boutron-Ruault MC, Senesse P, Meance S, Belghiti C, Faivre J (2001). Energy intake, body mass index, physical activity, and the colorectal adenomacarcinoma sequence. Nutr Cancer, 39, 50-7.
  7. Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe, 2004. Ann Oncol, 16, 481-8.
  8. Cao HX, Gao CM, Takezaki T, et al (2008). Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev, 9, 203-8.
  9. Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94.
  10. Chandy S, Sadananda Adiga MN, Ramachandra N, et al (2010). Association of methylenetetrahydrofolate reductase gene polymorphisms and colorectal cancer in India. Indian J Med Res, 131, 659-64.
  11. Chang SC, Lin PC, Lin JK, et al (2007). Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis, 22, 483-9.
  12. Chen J, Giovannucci E, Kelsey K, et al (1996). A methylenetetrahydro folate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862 4864.
  13. Cui LH, Shin MH, Kweon SS, et al (2010). Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer, 10, 236.
  14. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
  15. Ding XP, Feng L, Ma L (2012). MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 3937-42.
  16. Duthie SJ (1999). Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull, 55, 578-92.
  17. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
  18. El Awady MK, Karim AM, Hanna LS, et al (2009). Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals. Cancer Biomark, 5, 233 240.
  19. Fenech M (2001). The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat Res, 475, 57-67.
  20. Ferlay J, Shin HR, Bray F, et al (2008). Cancer Incidence and Mortality Worldwide: GLOBOCAN 2008, IARC Cancer Base No. 10, 1.2.
  21. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methelenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
  22. Fu LY, Dai LM, Li XG, Zhang K, Bai Y (2013). Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update. Euro J Obstet Gynecol Repro Biol, 6, 8272-6.
  23. Galvan-Portillo MV, Cantoral A, Onate-Ocana LF, et al (2009). Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr, 48, 269-76
  24. Giovannucci E, Rimm EB, Ascherio A, et al (1995). Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst, 87, 265-73.
  25. Giovannucci E (2001). An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 10, 725-31.
  26. Goyette P, Sumner JS, Milos R, et al (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identifi-cation. Nat Genet, 7, 195-200.
  27. Haghighi MM, Radpour R, Mahmoudi T, et al (2009). Association between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer. Oncol Res, 18, 57-63.
  28. Huang P, Zhou ZY, Ma HT, et al (2003). MTHFR polymorphisms and colorectal cancer susceptibility in Chongqing people. Acta Academiae Med Militaris Tertiae, 25, 1710-3.
  29. Jang MJ, Kim JW, Jeon YJ, et al (2013). Polymorphisms of folate metabolism-related genes and survival of patients with colorectal cancer in the Korean population. GENE, 7, 39056.
  30. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
  31. Jiang Q, Chen K, Ma X, et al (2005). Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev, 29, 146-54.
  32. Jin XX, Zhu ZZ, Wang AZ, Jia HR (2007). Association of methy-lenetetrahydrofolate reductase C677T polymorphism with genetic susceptibility to colorectal cancer. World Chin J Digestol, 15, 2754-7.
  33. Jin F, Qu LS, Shen XZ (2009). Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol, 4, 39.
  34. Kang BS, Ahn DH, Kim NK, Kim JW (2011). Relationship between metabolic syndrome and MTHFR polymorphism in colorectal cancer. J Korean Soc Coloproctol, 27, 78 82.
  35. Kennedy, DA, Stern SJ, Matok I, et al (2012). FolatesIntake, MTHFR Polymorphisms, and the Risk of colorectal cancer: a systematic review and meta- analysis. J Cancer Epidemiol, 2012, 952508.
  36. Kim YI (2003). Role of folate in colon cancer development and progression. J Nutrit, 133, 3731-9.
  37. Kim DH, Ahn YO, Lee BH, Tsuji E, Kiyohara C, Kono S (2004). Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett, 216, 199-205.
  38. Kim JW, Park HM, Choi YK, et al (2011). olymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients. Oncol Rep, 25, 167-72.
  39. Kim J, Cho YA, Kim DH, et al (2012). Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am J Clin Nutr, 95, 405 412.
  40. Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE (2005). The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1198-203.
  41. Li H, Xu WL, Shen HL, et al (2011). Methylenetetrahydrofolate reductase genotypes and haplotypes associated with susceptibility to colorectal cancer in an eastern Chinese Han population. Genet Mol Res, 10, 3738-46.
  42. Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
  43. Mantel N, Haenszel W (1956). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  44. Matsuo K, Hamajima N, Hirai T, et al (2002). Methionine synthase reductase gene A66G poly morphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev, 3, 353-9.
  45. Matsuo K, Ito H, Wakai K, et al (2005). One carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis, 26, 2164-71.
  46. Mei Q, Zhou D, Gao J, et al (2012).The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer, 12, 467-76.
  47. Miao XP, Yang S, Tan W, Zhang XM, et al (2005). Association between genetic variations in methylenetetrahydrofolate reductase and risk of colorectal cancer in a Chinese population. Chin J Prev Med, 39, 409-11.
  48. Mokarram P, Naghibalhossaini F, Saberi Firoozi M, et al (2008). Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J Gastroenterol, 14, 3662-71.
  49. Naghibalhossaini F, Mokarram P, Khalili I, et al (2010). MTHFR C677T and A1298C variant genotypes and the risk of microsatellite insta bility among Iranian colorectal cancer patients. Cancer Genet Cytogenet, 197, 142-51.
  50. Niu YM, Shen M, Li H, et al (2012). No association between MTHFR A1298C gene polymorphism and head and neck cancer risk: a metaanalysis based on 9, 952 subjects. Asian Pac J Cancer Prev, 13, 3943-7.
  51. Otani T, Iwasaki M, Hanaoka T, et al (2005). Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital based case control study in Japan. Nutr Cancer, 53, 42 50.
  52. Ozen F, Metin Sen M, Ozturk Ozdemir O (2014). Methylenetetrahydrofolate reductase gene germ-line C677T and A1298C SNPs are associated with colorectal cancer risk in the turkish population. Asian Pac J Cancer Prev, 15, 7731-5.
  53. Park KS, Mok JW, Kim JC (1999). The 677C > T mutation in 5, 10 methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test, 3, 233 236.
  54. Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41.<827::AID-IJC6>3.0.CO;2-P
  55. Prasad VV, Wilkhoo H (2011). Association of the functional poly morphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie, 34, 422-6.
  56. Promthet SS, Pientong C, Ekalaksananan T, et al (2010). Risk factors for colon cancer in Northeastern Thailand: interaction of MTHFR codon 677 and 1298 genotypes with environmental factors. J Epidemiol, 20, 329-38.
  57. Qin YT, Zhang Y, Wu F, et al (2014). Association between MTHFR polymorphisms and acute myeloid leukemia risk: a meta-analysis. Plos one, 9, 88823.
  58. Rai V, Yadav U, Kumar P, Yadav SK, Mishra OP (2014) Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies. Plos One, 9, 108552.
  59. Rai V (2014a). Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in asian populations. Asian Pac J Cancer Prev, 15, 9259-64.
  60. Rai V (2014 b). The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Asian populations. Asian Pac J Cancer Prev, 15, 5853-60.
  61. Russo A, Franceschi S, La Vecchia C, et al (1998). Body size and colorectal-cancer risk. Int J Cancer, 78, 161-5.<161::AID-IJC7>3.0.CO;2-X
  62. Ryan BM, Weir DG (2001). Relevance of folate metabolism in the pathogenesis of colorectal cancer. J Laboratory Clin Med, 138, 164-76.
  63. Sachse C, Smith G, Wilkie MJ, et al (2002). Colorectal cancer study group: a pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis, 23, 1839-49.
  64. Sameer AS, Shah ZA, Nissar S, Mudassar S, Siddiqi MA (2011). Risk of colorectal cancer associated with the methylenetetra hydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population. Genet Mol Res, 10, 1200-10.
  65. Shannon B, Gnanasampanthan S, Beilby J, Iacopetta B (2002). A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite insta bility. Gut, 50, 520-4.
  66. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M (1999). Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 8, 513-8.
  67. Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5.
  68. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283, 2008-12.
  69. Tu YL, Wang SB, Tan XL (2012). MTHFR Gene polymorphisms are not involved in pancreatic cancer risk: A meta-analysis. Asian Pac J Cancer Prev, 13, 4627-30.
  70. Wang J, Gajalakshmi V, Jiang J, et al (2006). Associations between 5, 10-ethylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: A case-control study in an Indian population. Int J Cancer, 118, 991-7.
  71. Weiwei Z, Liping C, Dequan L (2014). Association between dietary intake of folate, Vitamin B6, B12 & MTHFR, MTR Genotype and breast cancer risk. Pak J Med Sci, 30, 106-10.
  72. Wen YY, Yang SJ, Zhang JX, Chen XY (2013). Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 14, 21-25.
  73. Yan L, Zhao L, Long Y, et al (2012). Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. Plos One, 7, 41689.
  74. Yan Y, Hongjie Liang H, Ruolin Li R, et al (2013). XRCC3 Thr 241 Met polymorphism and ovarian cancer risk: a metaanalysis. Tumor Biol, 35, 2711-5.
  75. Yang XX, Li FX, Yi J, et al (2010). An association of methylenetetrahydrofolate reductase reductase C677T and gastric cancer, colorectal cancer and lung cancer susceptibility. Guangdong Med J, 31, 2375-7.
  76. Yin G, Kono S, Toyomura K, et al (2004). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the fukuoka colorectal cancer study. Cancer Sci, 95, 908-13.
  77. Yin G, Ming H, Zheng X, et al (2012). Methylenetetrahydrofolate reductase C677T gene polymorphism and colorectal cancer risk: A case control study. Oncol Lett, 4, 365-9.
  78. You W, Li Z, Jing C, et al (2013). MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis. DNA Cell Biol, 32, 260-7.
  79. Yousef A, Shomaf M, Berger S, et al (2014). Allele and genotype frequencies of the polymorphic methylenetetrahydrofolate reductase and colorectal cancer among jordanian population. Asian Pac J Cancer Prev, 14, 4559-65.
  80. Zeybek U, Yaylim I, Yilmaz H, et al (2007). Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct, 25, 419-22.
  81. Zhang YL, Yuan XY, Zhang Z, et al (2008). Relationship of genetic poly-morphisms in methylenetetrahydrofolate reductase and alcohol drinking with the risk of colorectal cancer. Chin J Cancer Prev Treat, 15, 1298-301.
  82. Zhang P, Gao X, Zhang Y, et al (2014). Association between MTHFR C677T polymorphism and venous thromboembolism risk in the chinese population: a meta-analysis of 24 casecontrolled studies. Angiol, 3319714546368.
  83. Zhu F, Wang YM, QY Z (2010). A case control study of plasma homocysteine, serum folate, the polymorphism of methylenetet-rahydrofolate reductase in colorectal cancer. J Southeast Univ Med Sci Edi, 29, 88 92.
  84. Zhu Q, Jin Z, Yuan Y, Lu Q, Ge D, Zong M (2011). Impact of MTHFR gene C677T polymorphism on Bcl 2 gene meth-ylation and protein expression in colorectal cancer. Scand J Gastroenterol, 46, 436-45.
  85. Zhuo X, Ling J, Zhou Y, et al (2012). Polymorphisms of MTHFR C677T and A1298C association with oral carcinoma risk: A Meta-Analysis. Cancer Investigat, 30, 447-52.
  86. Zintzaras E (2006). Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet, 51, 618-24.
  87. Zintzaras E, Lau J (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol, 61, 634-45.

Cited by

  1. rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case–control study and meta-analysis vol.17, pp.17, 2016,
  2. Strong Association of C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene With Nosyndromic Cleft Lip/Palate (nsCL/P) pp.0974-0422, 2017,
  3. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy pp.1590-3478, 2018,
  4. The association between MTHFR polymorphism and cervical cancer vol.8, pp.1, 2018,